Hungary approves China's Sinopharm Covid-19 vaccine
Hungary authorized the use of China's Sinopharm Covid-19 vaccine, Hungarian Chief Medical Officer Cecilia Muller said.
"Today the National Institute of Pharmacy and Nutrition gave its approval for the Sinopharm vaccine," Muller told a briefing, Xinhua news agency reported on Saturday.
Besides the Pfizer-BioNTech and Moderna vaccines acquired through the European Union, Hungary has also approved Russia's Sputnik V and the British AstraZeneca Covid-19 vaccines.
As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.
Meanwhile, 236 candidate vaccines are still being developed worldwide -- 63 of them in clinical trials -- in countries including Germany, China, Russia, Britain and the United States, according to information released by the World Health Organization on Tuesday.
Visit news.dtnext.in to explore our interactive epaper!
Download the DT Next app for more exciting features!
Click here for iOS
Click here for Android